TELUS
TU
7.94
+0.06
+0.76%
TELUS
US · TU
#1227 by market cap
Listed 1970
7.94
+0.06
+0.76%
Live - 5344 symbols - heartbeat 179s ago
· 2026-10-08 08:13
Pre-market
7.96
+0.25%
After-hours
7.97
+0.38%
- Market cap
- 12.51B
- P/E (TTM)i
- -19.18
- P/Bi
- 1.34
- EPSi
- 0.51
- Div yieldi
- 14.82%
- 52W posi
- 3%
Reader sentiment
Are you bullish or bearish on TU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.64, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.03% YoY
Margins
- Gross margin
- 62.13%
- Operating margin
- 13.31%
- Net margin
- 5.47%
Key ratios & quality
- Enterprise valuei
- 41.34B
- Altman Z-Scorei
- 0.64
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 14.10B | 14.59B | 15.34B | 16.84B | 18.29B | 20.01B | 20.14B | 20.35B |
| Gross profit | 7.73B | 8.52B | 9.07B | 10.14B | 11.19B | 12.47B | 12.50B | 12.64B |
| Selling & admin expenses | 2.90B | 3.03B | 3.70B | 4.27B | 4.90B | 6.15B | 5.91B | 5.88B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.59B | 2.93B | 2.37B | 2.66B | 2.84B | 2.26B | 2.56B | 2.71B |
| Pretax profit | 2.18B | 2.24B | 1.71B | 2.28B | 2.32B | 1.09B | 1.23B | 1.20B |
| Tax | 552.00M | 468.00M | 451.00M | 580.00M | 604.00M | 222.00M | 290.00M | 425.00M |
| Net profit | 1.62B | 1.78B | 1.26B | 1.70B | 1.72B | 867.00M | 938.00M | 777.00M |
| Basic EPS | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Diluted EPS | 1.34 | 1.45 | 0.94 | 1.22 | 1.15 | 0.58 | 0.67 | 0.72 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.02B | 5.03B | 5.07B | 5.23B | 4.99B | 4.92B |
| Gross profit | 3.17B | 3.17B | 3.13B | 3.17B | 3.13B | 3.05B |
| Selling & admin expenses | 1.47B | 1.55B | 1.41B | 1.46B | 1.64B | 1.47B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 706.00M | 619.00M | 696.00M | 687.00M | 502.00M | 549.00M |
| Pretax profit | 408.00M | -198.00M | 588.00M | 404.00M | 199.00M | -1.99B |
| Tax | 107.00M | 47.00M | 157.00M | 114.00M | 55.00M | -162.00M |
| Net profit | 301.00M | -245.00M | 431.00M | 290.00M | 144.00M | -1.83B |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | -1 |
| Diluted EPS | 0.21 | 0.00 | 0.32 | 0.19 | 0.09 | -1.17 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.84B | 4.35B | 4.68B | 5.03B | 6.09B | 6.31B | 6.63B | 8.37B |
| Cash & ST investments | 414.00M | 535.00M | 848.00M | 723.00M | 974.00M | 864.00M | 869.00M | 2.62B |
| Inventory | 376.00M | 437.00M | 407.00M | 448.00M | 537.00M | 484.00M | 629.00M | 482.00M |
| Total assets | 33.06B | 37.99B | 43.27B | 47.98B | 54.07B | 56.14B | 58.03B | 59.61B |
| Total current liabilities | 4.84B | 5.57B | 5.91B | 8.27B | 8.29B | 9.48B | 9.84B | 9.69B |
| Short-term debt | 936.00M | 1.43B | 1.53B | 3.04B | 2.65B | 4.10B | 4.17B | 4.02B |
| Long-term debt | 13.27B | 17.14B | 18.86B | 17.93B | 22.50B | 23.36B | 25.61B | 27.44B |
| Total liabilities | 22,716,000,000.00 | 27,326,000,000.00 | 30,705,000,000.00 | 31,924,000,000.00 | 36,411,000,000.00 | 38,834,000,000.00 | 41,230,000,000.00 | 43,034,000,000.00 |
| Total equity | 10.34B | 10.66B | 12.57B | 16.06B | 17.66B | 17.30B | 16.80B | 16.58B |
| Retained earnings | 4.47B | 4.37B | 3.71B | 4.26B | 4.10B | 2.84B | 1.52B | 98.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 6.72B | 9.32B | 7.39B | 8.37B | 7.17B | 7.11B |
| Cash & ST investments | 1.01B | 3.68B | 1.83B | 2.62B | 1.30B | 1.39B |
| Inventory | 566.00M | 485.00M | 455.00M | 482.00M | 458.00M | 461.00M |
| Total assets | 57.99B | 60.63B | 58.86B | 59.61B | 58.85B | 56.81B |
| Total current liabilities | 10.49B | 10.89B | 9.75B | 9.69B | 10.71B | 10.68B |
| Short-term debt | 5.10B | 5.39B | 4.12B | 4.02B | 5.01B | 5.03B |
| Long-term debt | 24.95B | 27.73B | 25.79B | 27.44B | 26.04B | 26.43B |
| Total liabilities | 41,199,000,000.00 | 44,526,000,000.00 | 41,341,000,000.00 | 43,034,000,000.00 | 42,487,000,000.00 | 42,723,000,000.00 |
| Total equity | 16.79B | 16.10B | 17.52B | 16.58B | 16.37B | 14.09B |
| Retained earnings | 1.23B | 630.00M | 500.00M | 98.00M | -406.00M | -2.91B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 4.06B | 3.93B | 4.57B | 4.39B | 4.81B | 4.50B | 4.85B | 4.87B |
| Depreciation & amortization | 2.27B | 2.58B | 3.01B | 3.22B | 3.45B | 4.07B | 3.96B | 4.04B |
| Free cash flow | 1.18B | 33.00M | 1.75B | -928.00M | 1.16B | 1.29B | 1.46B | 2.35B |
| Dividends paid | -1.14B | -1.15B | -930.00M | -1.05B | -1.19B | -1.32B | -1.56B | -1.63B |
| Stock buybacks / issuance | -100.00M | 0 | 1.50B | 1.30B | -- | -- | 0 | -40.00M |
| Ending cash balance | 414.00M | 535.00M | 848.00M | 723.00M | 974.00M | 864.00M | 869.00M | 2.62B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 1.08B | 1.17B | 1.49B | 1.13B | 1.05B | 1.34B |
| Depreciation & amortization | 992.00M | 1.00B | 1.01B | 1.03B | 988.00M | 1.03B |
| Free cash flow | 423.00M | 568.00M | 859.00M | 501.00M | -25.00M | 690.00M |
| Dividends paid | -402.00M | -405.00M | -408.00M | -413.00M | -430.00M | -434.00M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.01B | 3.68B | 1.83B | 2.62B | 1.30B | 1.39B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.32 | 16.78 | 10.67 | 12.17 | 10.19 | 5.15 | 6.26 | 7.09 |
| ROA %i | 5.11 | 4.92 | 2.97 | 3.62 | 3.17 | 1.53 | 1.74 | 1.89 |
| ROIC %i | 8.91 | 8.58 | 5.68 | 6.54 | 5.76 | 4.34 | 4.59 | 4.45 |
| 5-year avg ROE %i | 16.91 | 16.58 | 15.06 | 14.57 | 13.22 | 11.00 | 8.90 | 8.18 |
| EBIT margin %i | 19.99 | 20.24 | 16.02 | 18.31 | 17.43 | 11.91 | 13.12 | 13.39 |
| FCF / sales %i | 8.39 | 0.23 | 11.42 | -- | 6.36 | 6.44 | 7.25 | 11.56 |
| Current ratioi | 0.79 | 0.78 | 0.79 | 0.61 | 0.74 | 0.67 | 0.67 | 0.86 |
| Quick ratioi | 0.59 | 0.60 | 0.64 | 0.49 | 0.59 | 0.54 | 0.53 | 0.73 |
| Debt / assetsi | 42.96 | 48.90 | 47.11 | 43.69 | 46.50 | 48.90 | 51.31 | 52.77 |
| LT debt / equityi | 129.30 | 162.51 | 156.61 | 118.58 | 135.77 | 144.95 | 163.94 | 173.93 |
| Interest coveragei | 4.39 | 4.17 | 3.29 | 3.83 | 3.68 | 1.84 | 1.87 | 1.79 |
| Revenue CAGR (3Y) %i | 4.28 | 4.66 | 4.86 | 6.11 | 7.83 | 9.25 | 6.15 | 3.61 |
| Net income CAGR (3Y) %i | 5.00 | 12.60 | -8.18 | 1.13 | -2.57 | -11.35 | -15.66 | -11.67 |
| FCF CAGR (3Y) %i | -- | -53.20 | 26.48 | -- | 227.95 | -9.75 | -- | 26.41 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 7.51 | 6.23 | 7.45 | 7.09 | 5.96 | -6.45 |
| ROA %i | 2.05 | 1.64 | 2.04 | 1.89 | 1.59 | -1.57 |
| ROIC %i | 4.90 | 4.06 | 4.70 | 4.45 | 4.03 | 0.04 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.15 | 11.75 | 13.36 | 13.39 | 12.62 | 4.16 |
| FCF / sales %i | 9.21 | 10.83 | 11.33 | 11.56 | 9.37 | 10.02 |
| Current ratioi | 0.64 | 0.86 | 0.76 | 0.86 | 0.67 | 0.67 |
| Quick ratioi | 0.50 | 0.72 | 0.61 | 0.73 | 0.54 | 0.52 |
| Debt / assetsi | 51.82 | 54.62 | 50.81 | 52.77 | 52.76 | 55.37 |
| LT debt / equityi | 159.85 | 182.19 | 162.47 | 173.93 | 167.35 | 199.00 |
| Interest coveragei | 2.03 | 1.66 | 1.83 | 1.79 | 1.63 | 0.51 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- TELUS technology solutions is the largest reported line at 75.98% of revenue, across 4 reported segments.
- The next-largest line, TELUS digital experience, is a distant second at 15.71% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
TELUS technology solutions75.98%
TELUS digital experience15.71%
TELUS health10.89%
Quote time 2026-10-08 08:13:03 · For reference only, not investment advice and not tailored to your situation.